Lowering the Cost of Prescription Drugs Act of 2026
The Lowering the Cost of Prescription Drugs Act of 2026 (B 26-0593) authorizes the Mayor to partner with ArrayRX, a multi-state prescription drug discount program, to create a citywide drug discount card program for all District residents. This program would provide access to lower-cost prescription drugs regardless of insurance status (public, private, or none), expanding beyond existing targeted laws like the Insulin Affordability Act. The key mechanism is a cooperative purchasing agreement that leverages collective buying power to secure deeper discounts than individual consumers could achieve. It directly affects all DC residents facing high drug costs, aiming to reduce out-of-pocket expenses for medications. The bill does not alter insurance coverage but creates a new access point through this partnership.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2026
Committee Review
Floor Vote
Governor
Introduced Feb 2, 2026
Last action Mar 25, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
6
Key actions
0
Committee
1
Feb 3, 2026
Committee
Referred to Committee on Health
legislature
Feb 2, 2026
Introduced
B26-0593 Introduced by Councilmember Henderson at Office of the Secretary
legislature
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Christina Henderson
IIndependent
Ask Maddy
·
AI policy assistant
Ask Maddy about B 26-0593
Scope: DC
Hi! I can help you understand B 26-0593. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline